US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

6.74

+0.35005.48%

Post-market: 6.750.0100+0.15%16:58 EST

Volume:6.40M

Turnover:42.38M

Market Cap:618.58M

PE:4.14

High:6.78

Open:6.42

Low:6.32

Close:6.39

52wk High:19.70

52wk Low:6.18

Shares:91.78M

Float Shares:87.27M

Volume Ratio:1.55

T/O Rate:7.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.63

EPS(LYR):-0.5920

ROE:66.13%

ROA:-0.59%

PB:1.93

PE(LYR):-11.39

Loading ...

Overview Company News Filings

NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

Press Release: Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock

NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy

XPEL And 2 Stocks That Could Be Trading Below Estimated Value

Simply Wall St.

Hong Kong Stock Alert | CSTONE PHARMA-B (02616) Rises Over 3% as Company to Present PD-1/VEGF/CTLA-4 Trispecific Antibody Phase I Dose Escalation Clinical Data at ESMO Conference

CStone Pharma-B (02616) to Unveil Phase I Dose Escalation Clinical Data for PD-1/VEGF/CTLA-4 Triple Antibody and Latest Research Design for ROR1 ADC

Strategic Advancements and Potential in Oncology: Kazia Therapeutics’ Buy Rating Driven by Novel PD-L1 Degrader and AI-Driven Paxalisib Development

Annovis Announces $6 Million Registered Direct Offering of Common Stock

How Investors May Respond To PagerDuty (PD) Unveiling Its End-to-End AI Agent Suite and Automation Upgrades

Simply Wall St.

Shanxi Securities Company Limited Initiates Coverage on 3SBIO (01530) with "Buy-B" Rating: PD-1/VEGF Bispecific Antibody Shows Promise as Potential Cornerstone Cancer Therapy

Tianfeng Securities: Maintains "Buy" Rating on ABBISKO-B (02256) with Oral PD-L1 and Multi-Drug Combination Strategy

A Fresh Look at PagerDuty (PD) Valuation Following Recent Share Pressure and Revenue Growth Trends

Simply Wall St.

Regeneron says FDA approves PD-1 inhibitor Libtayo

PagerDuty (PD) Stock Is Up, What You Need To Know

stock_story_highlight

Kazia Therapeutics signs collaboration and in-licensing agreement for PD-L1

Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC

Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study

Benzinga_recent_news

Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PD/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","market":"US","secType":"STK","nameCN":"PagerDuty, Inc.","latestPrice":6.74,"timestamp":1772053200000,"preClose":6.39,"halted":0,"volume":6402033,"hourTrading":{"tag":"盘后","latestPrice":6.75,"preClose":6.74,"latestTime":"16:58 EST","volume":86064,"amount":580152.776544,"timestamp":1772056694582,"change":0.01,"changeRate":0.001484,"amplitude":0.014837},"delay":0,"changeRate":0.05477308294209711,"floatShares":87273400,"shares":91776804,"eps":1.62968,"marketStatus":"Post-Mkt","change":0.35,"latestTime":"02-25 17:30:21 EST","open":6.42,"high":6.775,"low":6.315,"amount":42380508.3983028,"amplitude":0.071987,"askPrice":7,"askSize":200,"bidPrice":6.59,"bidSize":15,"shortable":3,"etf":0,"ttmEps":1.62968,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772067600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1554955200000,"exchange":"NYSE","adjPreClose":6.39,"preHourTrading":{"tag":"盘前","latestPrice":6.55,"preClose":6.39,"latestTime":"09:21 EST","volume":604,"amount":3949.3299228,"timestamp":1772029317219,"change":0.16,"changeRate":0.025039,"amplitude":0.028169},"postHourTrading":{"tag":"盘后","latestPrice":6.75,"preClose":6.74,"latestTime":"16:58 EST","volume":86064,"amount":580152.776544,"timestamp":1772056694582,"change":0.01,"changeRate":0.001484,"amplitude":0.014837},"volumeRatio":1.546569,"impliedVol":1.0361,"impliedVolPercentile":0.9641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","floatShares":87273400,"roa":"-0.59%","roe":"66.13%","lyrEps":-0.591956,"volumeRatio":1.546569,"shares":91776804,"dividePrice":0,"high":6.775,"amplitude":0.071987,"preClose":6.39,"low":6.315,"week52Low":6.18,"pbRate":"1.93","psRate":"1.26","week52High":19.7,"institutionHeld":0,"latestPrice":6.74,"committee":-0.860465,"eps":1.62968,"divideRate":0,"volume":6402033,"delay":0,"ttmEps":1.62968,"open":6.42,"prevYearClose":13.11,"prevWeekClose":6.57,"prevMonthClose":10.6,"prevQuarterClose":13.11,"fiveDayClose":6.95,"twentyDayClose":10.97,"sixtyDayClose":11.64,"earningDate":1773244800000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PD\",params:#limit:5,,,undefined,":[{"date":"2026-03-12","symbol":"PD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/01","expectedEps":0.04,"defaultRemindTime":1773345600000,"name":null,"time":"Post Market","dateTimestamp":1773288000000,"actualEps":null},{"market":"US","date":"2025-11-25","symbol":"PD","fiscalQuarterEnding":"2025/10","expectedEps":0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1764046800000,"reportTimeType":"post","actualEps":0.15},{"date":"2025-09-03","symbol":"PD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/07","expectedEps":-0.02,"defaultRemindTime":1756929600000,"name":null,"time":"Post Market","dateTimestamp":1756872000000,"actualEps":null},{"market":"US","date":"2025-05-29","symbol":"PD","fiscalQuarterEnding":"2025/04","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1748491200000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-03-13","symbol":"PD","fiscalQuarterEnding":"2025/01","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.3333,"hold":0.4444,"sell":0.1111,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4444,"analysts":9,"updateTime":1767934800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PD","date":"2026-02-24","current":4.135781,"percent":0.951118,"low":-115.332138,"twenty":-38.764801,"median":-23.537754,"eighty":-19.535333,"high":9.29824,"avg":-29.546976,"sd":21.210485,"marketCap":571965131},"quantilePoints":[{"date":"2021-02-26","current":-64.090797,"twenty":-69.256452,"median":-45.616009,"eighty":-38.656949,"marketCap":3665673158},{"date":"2021-03-05","current":-53.862628,"twenty":-69.159583,"median":-45.671397,"eighty":-38.66724,"marketCap":3080673016},{"date":"2021-03-12","current":-60.509506,"twenty":-69.072496,"median":-45.726784,"eighty":-38.673459,"marketCap":3460841176},{"date":"2021-03-19","current":-49.639711,"twenty":-68.918379,"median":-45.797998,"eighty":-38.687063,"marketCap":3420324980},{"date":"2021-03-26","current":-46.372989,"twenty":-68.782324,"median":-45.852876,"eighty":-38.706425,"marketCap":3195238028},{"date":"2021-04-01","current":-49.627656,"twenty":-68.703922,"median":-45.852876,"eighty":-38.74149,"marketCap":3419494401},{"date":"2021-04-09","current":-50.688437,"twenty":-68.634603,"median":-45.95625,"eighty":-38.792193,"marketCap":3492585367},{"date":"2021-04-16","current":-50.965686,"twenty":-68.620415,"median":-46.098464,"eighty":-38.810779,"marketCap":3511688688},{"date":"2021-04-23","current":-50.965686,"twenty":-68.551655,"median":-46.177802,"eighty":-38.849388,"marketCap":3511688688},{"date":"2021-04-30","current":-51.182664,"twenty":-68.073194,"median":-46.296231,"eighty":-38.932876,"marketCap":3526639113},{"date":"2021-05-07","current":-45.52431,"twenty":-67.425697,"median":-46.35136,"eighty":-39.005886,"marketCap":3136761501},{"date":"2021-05-14","current":-42.286432,"twenty":-67.150653,"median":-46.187891,"eighty":-39.046881,"marketCap":2913662055},{"date":"2021-05-21","current":-44.081211,"twenty":-66.824039,"median":-46.121291,"eighty":-39.054259,"marketCap":3037327665},{"date":"2021-05-28","current":-49.295769,"twenty":-66.574781,"median":-46.172553,"eighty":-39.081958,"marketCap":3396626399},{"date":"2021-06-04","current":-36.968776,"twenty":-66.216652,"median":-46.172553,"eighty":-39.072116,"marketCap":2957576028},{"date":"2021-06-11","current":-42.279901,"twenty":-66.096321,"median":-46.075636,"eighty":-39.072116,"marketCap":3382476656},{"date":"2021-06-18","current":-45.709132,"twenty":-65.976077,"median":-45.923735,"eighty":-39.125091,"marketCap":3656821944},{"date":"2021-06-25","current":-47.162372,"twenty":-65.815901,"median":-46.067026,"eighty":-39.183405,"marketCap":3773084124},{"date":"2021-07-02","current":-44.130431,"twenty":-65.216755,"median":-46.011638,"eighty":-39.205083,"marketCap":3530522741},{"date":"2021-07-09","current":-45.834591,"twenty":-65.021933,"median":-45.883552,"eighty":-39.229781,"marketCap":3666858967},{"date":"2021-07-16","current":-40.199362,"twenty":-64.900098,"median":-45.829869,"eighty":-39.313533,"marketCap":3216029363},{"date":"2021-07-23","current":-43.325398,"twenty":-64.76408,"median":-45.766347,"eighty":-39.330284,"marketCap":3466118512},{"date":"2021-07-30","current":-42.436726,"twenty":-64.636745,"median":-45.712576,"eighty":-39.369202,"marketCap":3395022935},{"date":"2021-08-06","current":-44.33953,"twenty":-64.491902,"median":-45.685037,"eighty":-39.631794,"marketCap":3547251112},{"date":"2021-08-13","current":-42.269446,"twenty":-64.377301,"median":-45.655572,"eighty":-39.648544,"marketCap":3381640238},{"date":"2021-08-20","current":-40.387552,"twenty":-64.32,"median":-45.516041,"eighty":-39.732297,"marketCap":3231084897},{"date":"2021-08-27","current":-43.743597,"twenty":-64.248374,"median":-45.492434,"eighty":-39.784241,"marketCap":3499575255},{"date":"2021-09-03","current":-42.390054,"twenty":-64.090797,"median":-45.440934,"eighty":-39.784241,"marketCap":4025995391},{"date":"2021-09-10","current":-39.410762,"twenty":-63.838675,"median":-45.357157,"eighty":-39.773852,"marketCap":3743037083},{"date":"2021-09-17","current":-42.488469,"twenty":-63.43184,"median":-45.291593,"eighty":-39.773852,"marketCap":4035342362},{"date":"2021-09-24","current":-41.531159,"twenty":-63.322968,"median":-45.131991,"eighty":-39.806871,"marketCap":3944421825},{"date":"2021-10-01","current":-37.845067,"twenty":-63.294318,"median":-44.969953,"eighty":-39.673042,"marketCap":3594335269},{"date":"2021-10-08","current":-35.304169,"twenty":-63.234694,"median":-44.895964,"eighty":-39.361418,"marketCap":3353013468},{"date":"2021-10-15","current":-36.968279,"twenty":-62.977151,"median":-44.757709,"eighty":-39.195032,"marketCap":3511062253},{"date":"2021-10-22","current":-37.567716,"twenty":-62.673,"median":-44.689179,"eighty":-39.048237,"marketCap":3567993805},{"date":"2021-10-29","current":-37.352992,"twenty":-62.144822,"median":-44.662724,"eighty":-38.884343,"marketCap":3547600413},{"date":"2021-11-05","current":-38.927633,"twenty":-61.970673,"median":-44.622066,"eighty":-38.780249,"marketCap":3697151952},{"date":"2021-11-12","current":-37.684024,"twenty":-61.914834,"median":-44.517265,"eighty":-38.690435,"marketCap":3579040225},{"date":"2021-11-19","current":-34.892615,"twenty":-61.891288,"median":-44.350719,"eighty":-38.663132,"marketCap":3313926135},{"date":"2021-11-26","current":-33.094304,"twenty":-61.87812,"median":-44.340807,"eighty":-38.647574,"marketCap":3143131480},{"date":"2021-12-03","current":-27.717262,"twenty":-61.851785,"median":-44.310434,"eighty":-38.490518,"marketCap":2632446965},{"date":"2021-12-10","current":-29.437491,"twenty":-61.634212,"median":-44.193031,"eighty":-38.342002,"marketCap":2964590848},{"date":"2021-12-17","current":-29.446029,"twenty":-61.446371,"median":-44.130431,"eighty":-38.122419,"marketCap":2965450648},{"date":"2021-12-23","current":-30.863263,"twenty":-61.141525,"median":-44.120926,"eighty":-37.910083,"marketCap":3108177469},{"date":"2021-12-31","current":-29.668005,"twenty":-60.679678,"median":-44.096614,"eighty":-37.767931,"marketCap":2987805451},{"date":"2022-01-07","current":-27.243339,"twenty":-60.561077,"median":-44.020576,"eighty":-37.685906,"marketCap":2743622214},{"date":"2022-01-14","current":-26.466422,"twenty":-60.402519,"median":-43.931787,"eighty":-37.609143,"marketCap":2665380403},{"date":"2022-01-21","current":-25.715117,"twenty":-60.229637,"median":-43.82863,"eighty":-37.535067,"marketCap":2589717991},{"date":"2022-01-28","current":-27.448241,"twenty":-60.179262,"median":-43.748751,"eighty":-37.457573,"marketCap":2764257417},{"date":"2022-02-04","current":-27.106738,"twenty":-60.125395,"median":-43.643849,"eighty":-37.310047,"marketCap":2729865412},{"date":"2022-02-11","current":-28.728874,"twenty":-59.884929,"median":-43.550718,"eighty":-37.143446,"marketCap":2893227437},{"date":"2022-02-18","current":-27.106738,"twenty":-59.724487,"median":-43.492185,"eighty":-36.968378,"marketCap":2729865412},{"date":"2022-02-25","current":-28.071482,"twenty":-59.678646,"median":-43.437917,"eighty":-36.905651,"marketCap":2827022827},{"date":"2022-03-04","current":-25.322389,"twenty":-59.583656,"median":-43.360924,"eighty":-36.834452,"marketCap":2550167185},{"date":"2022-03-11","current":-22.70136,"twenty":-59.306192,"median":-43.319423,"eighty":-36.766338,"marketCap":2286208545},{"date":"2022-03-18","current":-28.291592,"twenty":-59.172166,"median":-43.295217,"eighty":-36.444632,"marketCap":3040073042},{"date":"2022-03-25","current":-28.785804,"twenty":-59.048339,"median":-43.241759,"eighty":-36.064649,"marketCap":3093178556},{"date":"2022-04-01","current":-27.724464,"twenty":-59.048339,"median":-43.1764,"eighty":-35.678665,"marketCap":2979132288},{"date":"2022-04-08","current":-25.415442,"twenty":-58.958192,"median":-43.086807,"eighty":-35.293402,"marketCap":2731016361},{"date":"2022-04-14","current":-26.428171,"twenty":-58.866018,"median":-43.039133,"eighty":-34.945236,"marketCap":2839839136},{"date":"2022-04-22","current":-23.843687,"twenty":-58.778063,"median":-42.940117,"eighty":-34.48789,"marketCap":2562123414},{"date":"2022-04-29","current":-23.14693,"twenty":-58.704534,"median":-42.888728,"eighty":-33.407653,"marketCap":2487253345},{"date":"2022-05-06","current":-21.039181,"twenty":-58.614907,"median":-42.82356,"eighty":-33.196501,"marketCap":2260765197},{"date":"2022-05-13","current":-21.537198,"twenty":-58.533862,"median":-42.744231,"eighty":-33.138326,"marketCap":2314279623},{"date":"2022-05-20","current":-19.528801,"twenty":-58.506847,"median":-42.67719,"eighty":-32.784627,"marketCap":2098467346},{"date":"2022-05-27","current":-21.055509,"twenty":-58.47232,"median":-42.506172,"eighty":-32.56425,"marketCap":2262519768},{"date":"2022-06-03","current":-19.41561,"twenty":-58.365647,"median":-42.492303,"eighty":-32.253988,"marketCap":2285547362},{"date":"2022-06-10","current":-18.661968,"twenty":-58.119439,"median":-42.449993,"eighty":-31.627913,"marketCap":2196830881},{"date":"2022-06-17","current":-17.871017,"twenty":-57.794408,"median":-42.412967,"eighty":-30.853018,"marketCap":2103722495},{"date":"2022-06-24","current":-21.251213,"twenty":-57.545961,"median":-42.37641,"eighty":-30.527663,"marketCap":2501629088},{"date":"2022-07-01","current":-18.975364,"twenty":-57.27835,"median":-42.328632,"eighty":-30.205871,"marketCap":2233722883},{"date":"2022-07-08","current":-20.758734,"twenty":-57.119373,"median":-42.300639,"eighty":-29.937792,"marketCap":2443655942},{"date":"2022-07-15","current":-19.512613,"twenty":-57.022546,"median":-42.274674,"eighty":-29.686169,"marketCap":2296966315},{"date":"2022-07-22","current":-19.751391,"twenty":-56.538634,"median":-42.258991,"eighty":-29.576542,"marketCap":2325074507},{"date":"2022-07-29","current":-19.348454,"twenty":-55.37095,"median":-42.1379,"eighty":-29.489533,"marketCap":2277641933},{"date":"2022-08-05","current":-21.340755,"twenty":-54.581356,"median":-41.999461,"eighty":-29.249821,"marketCap":2512169660},{"date":"2022-08-12","current":-21.370602,"twenty":-54.282209,"median":-41.907002,"eighty":-28.899625,"marketCap":2515683184},{"date":"2022-08-19","current":-19.214141,"twenty":-54.164004,"median":-41.742363,"eighty":-28.761236,"marketCap":2261831075},{"date":"2022-08-26","current":-19.318607,"twenty":-54.013801,"median":-41.687142,"eighty":-28.490216,"marketCap":2274128409},{"date":"2022-09-02","current":-16.562766,"twenty":-53.825684,"median":-41.612639,"eighty":-28.401837,"marketCap":2096100841},{"date":"2022-09-09","current":-17.753369,"twenty":-53.67791,"median":-41.5952,"eighty":-28.368118,"marketCap":2246777593},{"date":"2022-09-16","current":-16.597991,"twenty":-53.584381,"median":-41.569297,"eighty":-28.257217,"marketCap":2100558733},{"date":"2022-09-23","current":-15.858267,"twenty":-53.533149,"median":-41.530643,"eighty":-28.105632,"marketCap":2006943000},{"date":"2022-09-30","current":-16.252786,"twenty":-53.345477,"median":-41.466004,"eighty":-27.873415,"marketCap":2056871391},{"date":"2022-10-07","current":-16.182337,"twenty":-53.110426,"median":-41.390601,"eighty":-27.717262,"marketCap":2047955607},{"date":"2022-10-14","current":-14.646529,"twenty":-52.79331,"median":-41.34773,"eighty":-27.636067,"marketCap":1853591514},{"date":"2022-10-21","current":-16.485271,"twenty":-52.578578,"median":-41.307589,"eighty":-27.328715,"marketCap":2086293479},{"date":"2022-10-28","current":-17.922449,"twenty":-52.484531,"median":-41.281723,"eighty":-27.012825,"marketCap":2268175475},{"date":"2022-11-04","current":-14.604259,"twenty":-52.445692,"median":-41.223096,"eighty":-26.683037,"marketCap":1848242043},{"date":"2022-11-11","current":-17.35885,"twenty":-52.440537,"median":-41.165581,"eighty":-26.46868,"marketCap":2196849202},{"date":"2022-11-18","current":-15.442613,"twenty":-51.97825,"median":-41.046215,"eighty":-26.415612,"marketCap":1954339874},{"date":"2022-11-25","current":-15.379208,"twenty":-51.971496,"median":-40.952393,"eighty":-26.24103,"marketCap":1946315669},{"date":"2022-12-02","current":-16.042428,"twenty":-51.941247,"median":-40.886211,"eighty":-26.002015,"marketCap":2129728606},{"date":"2022-12-09","current":-16.110204,"twenty":-51.872986,"median":-40.837833,"eighty":-25.713912,"marketCap":2138726192},{"date":"2022-12-16","current":-18.028246,"twenty":-51.7604,"median":-40.772608,"eighty":-25.598799,"marketCap":2393357876},{"date":"2022-12-23","current":-17.994359,"twenty":-51.70784,"median":-40.745253,"eighty":-25.338499,"marketCap":2388859083},{"date":"2022-12-30","current":-18.001136,"twenty":-51.570726,"median":-40.701201,"eighty":-25.184081,"marketCap":2389758841},{"date":"2023-01-06","current":-16.049206,"twenty":-51.363479,"median":-40.623172,"eighty":-24.85486,"marketCap":2130628364},{"date":"2023-01-13","current":-18.78733,"twenty":-51.102161,"median":-40.574619,"eighty":-24.231092,"marketCap":2494130839},{"date":"2023-01-20","current":-18.882216,"twenty":-50.978262,"median":-40.523325,"eighty":-23.99114,"marketCap":2506727459},{"date":"2023-01-27","current":-19.925957,"twenty":-50.965686,"median":-40.469321,"eighty":-23.312385,"marketCap":2645290284},{"date":"2023-02-03","current":-21.220466,"twenty":-50.951221,"median":-40.311267,"eighty":-22.57339,"marketCap":2817144176},{"date":"2023-02-10","current":-19.627745,"twenty":-50.890949,"median":-40.250171,"eighty":-21.596594,"marketCap":2605700905},{"date":"2023-02-17","current":-20.664708,"twenty":-50.876484,"median":-40.190227,"eighty":-21.430411,"marketCap":2743363971},{"date":"2023-02-24","current":-19.485417,"twenty":-50.857197,"median":-40.120759,"eighty":-21.251213,"marketCap":2586805975},{"date":"2023-03-03","current":-20.834146,"twenty":-50.688437,"median":-40.045986,"eighty":-21.055509,"marketCap":2765857936},{"date":"2023-03-10","current":-18.204462,"twenty":-50.646894,"median":-39.953806,"eighty":-20.967665,"marketCap":2416751599},{"date":"2023-03-17","current":-22.814647,"twenty":-50.628165,"median":-39.81605,"eighty":-20.881589,"marketCap":2929925462},{"date":"2023-03-24","current":-22.508745,"twenty":-50.547877,"median":-39.758269,"eighty":-20.937818,"marketCap":2890640524},{"date":"2023-03-31","current":-24.884826,"twenty":-50.538628,"median":-39.648544,"eighty":-20.967665,"marketCap":3195783993},{"date":"2023-04-06","current":-22.608341,"twenty":-50.398102,"median":-39.410762,"eighty":-20.985573,"marketCap":2903430969},{"date":"2023-04-14","current":-23.753697,"twenty":-50.260054,"median":-39.321908,"eighty":-21.029355,"marketCap":3050521084},{"date":"2023-04-21","current":-24.273021,"twenty":-50.211876,"median":-39.198908,"eighty":-21.041663,"marketCap":3117214118},{"date":"2023-04-28","current":-22.053448,"twenty":-50.10983,"median":-39.086878,"eighty":-21.052864,"marketCap":2832169920},{"date":"2023-05-05","current":-20.085339,"twenty":-50.030853,"median":-39.045525,"eighty":-21.029355,"marketCap":2579419472},{"date":"2023-05-12","current":-21.254175,"twenty":-50.011348,"median":-38.97946,"eighty":-20.981096,"marketCap":2729524925},{"date":"2023-05-19","current":-21.074906,"twenty":-49.936988,"median":-38.858126,"eighty":-20.935287,"marketCap":2706502616},{"date":"2023-05-26","current":-18.98821,"twenty":-49.739821,"median":-38.781427,"eighty":-20.865452,"marketCap":2438522942},{"date":"2023-06-02","current":-23.7011,"twenty":-49.634889,"median":-38.748697,"eighty":-20.83367,"marketCap":2555476271},{"date":"2023-06-09","current":-19.16437,"twenty":-49.587066,"median":-38.685442,"eighty":-20.780404,"marketCap":2066321490},{"date":"2023-06-16","current":-19.591955,"twenty":-49.518553,"median":-38.668128,"eighty":-20.758997,"marketCap":2112424156},{"date":"2023-06-23","current":-18.642716,"twenty":-49.490829,"median":-38.652026,"eighty":-20.740419,"marketCap":2010076237},{"date":"2023-06-30","current":-18.830853,"twenty":-49.425691,"median":-38.650282,"eighty":-20.728887,"marketCap":2030361410},{"date":"2023-07-07","current":-18.753888,"twenty":-49.321753,"median":-38.534252,"eighty":-20.640309,"marketCap":2022062930},{"date":"2023-07-14","current":-21.12271,"twenty":-49.135663,"median":-38.486364,"eighty":-20.586625,"marketCap":2277471700},{"date":"2023-07-21","current":-20.626711,"twenty":-49.077653,"median":-38.375503,"eighty":-20.595005,"marketCap":2223992607},{"date":"2023-07-28","current":-21.105606,"twenty":-49.061015,"median":-38.330676,"eighty":-20.595005,"marketCap":2275627593},{"date":"2023-08-04","current":-20.883262,"twenty":-49.007339,"median":-38.158206,"eighty":-20.613914,"marketCap":2251654207},{"date":"2023-08-11","current":-20.549746,"twenty":-48.954208,"median":-37.988814,"eighty":-20.586625,"marketCap":2215694127},{"date":"2023-08-18","current":-20.01954,"twenty":-48.941266,"median":-37.845067,"eighty":-20.541194,"marketCap":2158526822},{"date":"2023-08-25","current":-20.66947,"twenty":-48.894876,"median":-37.770349,"eighty":-20.506987,"marketCap":2228602874},{"date":"2023-09-01","current":-25.511357,"twenty":-48.832826,"median":-37.755599,"eighty":-20.541194,"marketCap":2375209352},{"date":"2023-09-07","current":-24.043412,"twenty":-48.807682,"median":-37.686377,"eighty":-20.560008,"marketCap":2238537799},{"date":"2023-09-14","current":-23.412009,"twenty":-48.750972,"median":-37.671633,"eighty":-20.577111,"marketCap":2179751687},{"date":"2023-09-22","current":-22.590183,"twenty":-48.595885,"median":-37.578261,"eighty":-20.58462,"marketCap":2103236431},{"date":"2023-09-28","current":-22.048981,"twenty":-48.583225,"median":-37.547623,"eighty":-20.587293,"marketCap":2052848336},{"date":"2023-10-05","current":-21.978825,"twenty":-48.576545,"median":-37.531928,"eighty":-20.595005,"marketCap":2046316545},{"date":"2023-10-11","current":-21.497757,"twenty":-48.562801,"median":-37.500901,"eighty":-20.605423,"marketCap":2001527127},{"date":"2023-10-20","current":-20.345196,"twenty":-48.534663,"median":-37.448341,"eighty":-20.589221,"marketCap":1894219146},{"date":"2023-10-27","current":-19.894194,"twenty":-48.514606,"median":-37.410785,"eighty":-20.580532,"marketCap":1852229066},{"date":"2023-11-03","current":-20.485508,"twenty":-48.433814,"median":-37.299311,"eighty":-20.506205,"marketCap":1907282726},{"date":"2023-11-10","current":-20.746087,"twenty":-48.370598,"median":-37.219715,"eighty":-20.506987,"marketCap":1931543661},{"date":"2023-11-17","current":-21.217133,"twenty":-48.32991,"median":-37.120374,"eighty":-20.524091,"marketCap":1975399966},{"date":"2023-11-24","current":-21.858558,"twenty":-48.320008,"median":-37.057747,"eighty":-20.549746,"marketCap":2035119191},{"date":"2023-11-30","current":-22.048981,"twenty":-48.252059,"median":-36.968279,"eighty":-20.57027,"marketCap":2052848336},{"date":"2023-12-07","current":-26.625426,"twenty":-48.121131,"median":-36.925787,"eighty":-20.578821,"marketCap":2015198621},{"date":"2023-12-15","current":-28.276615,"twenty":-48.00719,"median":-36.911135,"eighty":-20.582242,"marketCap":2140172179},{"date":"2024-01-05","current":-26.103359,"twenty":-47.918569,"median":-36.904212,"eighty":-20.585288,"marketCap":1975684923},{"date":"2024-01-12","current":-31.117632,"twenty":-47.865829,"median":-36.842529,"eighty":-20.591149,"marketCap":2355200212},{"date":"2024-01-19","current":-31.627558,"twenty":-47.844972,"median":-36.829603,"eighty":-20.601178,"marketCap":2393794988},{"date":"2024-01-26","current":-29.053645,"twenty":-47.78321,"median":-36.766338,"eighty":-20.619869,"marketCap":2198983265},{"date":"2024-02-02","current":-29.32075,"twenty":-47.731847,"median":-36.504107,"eighty":-20.628421,"marketCap":2219199576},{"date":"2024-02-09","current":-29.393596,"twenty":-47.672575,"median":-36.388531,"eighty":-20.635263,"marketCap":2224713115},{"date":"2024-02-16","current":-29.733547,"twenty":-47.618326,"median":-36.095963,"eighty":-20.635379,"marketCap":2250442965},{"date":"2024-02-23","current":-28.10664,"twenty":-47.602066,"median":-35.89466,"eighty":-20.635842,"marketCap":2127307254},{"date":"2024-03-01","current":-29.332891,"twenty":-47.570415,"median":-35.678665,"eighty":-20.651153,"marketCap":2220118499},{"date":"2024-03-08","current":-29.55143,"twenty":-47.518149,"median":-35.35785,"eighty":-20.660918,"marketCap":2236659117},{"date":"2024-03-15","current":-26.009561,"twenty":-47.49129,"median":-35.24315,"eighty":-20.664708,"marketCap":2126463652},{"date":"2024-03-22","current":-25.786705,"twenty":-47.380514,"median":-34.925503,"eighty":-20.66947,"marketCap":2108243640},{"date":"2024-03-28","current":-24.935846,"twenty":-47.342533,"median":-34.589879,"eighty":-20.66947,"marketCap":2038679948},{"date":"2024-04-05","current":-25.071983,"twenty":-47.312176,"median":-34.414946,"eighty":-20.689994,"marketCap":2049810139},{"date":"2024-04-12","current":-25.888808,"twenty":-47.269427,"median":-33.423363,"eighty":-20.697474,"marketCap":2116591283},{"date":"2024-04-19","current":-23.631195,"twenty":-47.158961,"median":-33.184171,"eighty":-20.697474,"marketCap":1932015619},{"date":"2024-04-26","current":-22.916473,"twenty":-46.951231,"median":-33.003753,"eighty":-20.698257,"marketCap":1873582118},{"date":"2024-05-03","current":-23.897861,"twenty":-46.656905,"median":-32.649248,"eighty":-20.698257,"marketCap":1953817432},{"date":"2024-05-10","current":-23.114516,"twenty":-46.598159,"median":-32.247909,"eighty":-20.698257,"marketCap":1889773514},{"date":"2024-05-17","current":-24.517522,"twenty":-46.43348,"median":-31.759443,"eighty":-20.698257,"marketCap":2004479038},{"date":"2024-05-24","current":-22.904066,"twenty":-46.181838,"median":-31.451512,"eighty":-20.698257,"marketCap":1872567685},{"date":"2024-05-31","current":-20.986625,"twenty":-46.068748,"median":-31.128449,"eighty":-20.698257,"marketCap":1715803469},{"date":"2024-06-07","current":-20.224161,"twenty":-45.830813,"median":-30.643949,"eighty":-20.66395,"marketCap":1892880316},{"date":"2024-06-14","current":-21.429439,"twenty":-45.725202,"median":-30.31849,"eighty":-20.645029,"marketCap":2005688335},{"date":"2024-06-21","current":-21.357939,"twenty":-45.671397,"median":-29.967092,"eighty":-20.641966,"marketCap":1998996334},{"date":"2024-06-28","current":-23.247571,"twenty":-45.51108,"median":-29.932669,"eighty":-20.635726,"marketCap":2175856364},{"date":"2024-07-05","current":-22.542789,"twenty":-45.42729,"median":-29.794252,"eighty":-20.635726,"marketCap":2109892353},{"date":"2024-07-12","current":-21.439653,"twenty":-45.27192,"median":-29.668005,"eighty":-20.635726,"marketCap":2006644335},{"date":"2024-07-15","current":-21.807365,"twenty":-45.165128,"median":-29.6527,"eighty":-20.635726,"marketCap":2041060341},{"date":"2024-08-02","current":-20.438659,"twenty":-44.67116,"median":-29.473821,"eighty":-20.619869,"marketCap":1912956320},{"date":"2024-08-09","current":-18.937169,"twenty":-44.592228,"median":-29.326821,"eighty":-20.554877,"marketCap":1772424296},{"date":"2024-08-16","current":-19.846234,"twenty":-44.342086,"median":-29.065787,"eighty":-20.488395,"marketCap":1857508310},{"date":"2024-08-23","current":-19.366166,"twenty":-44.293477,"median":-28.968658,"eighty":-20.439367,"marketCap":1812576303},{"date":"2024-08-30","current":-20.193518,"twenty":-44.126836,"median":-28.878841,"eighty":-20.396729,"marketCap":1890012316},{"date":"2024-09-06","current":-20.851386,"twenty":-44.070828,"median":-28.815003,"eighty":-20.350301,"marketCap":1731811836},{"date":"2024-09-13","current":-19.495653,"twenty":-43.902513,"median":-28.750118,"eighty":-20.261779,"marketCap":1619211496},{"date":"2024-09-20","current":-20.358392,"twenty":-43.724824,"median":-28.493474,"eighty":-20.244564,"marketCap":1690866258},{"date":"2024-09-27","current":-20.324779,"twenty":-43.52784,"median":-28.425739,"eighty":-20.226358,"marketCap":1688074514},{"date":"2024-10-04","current":-19.753355,"twenty":-43.367535,"median":-28.373476,"eighty":-20.209123,"marketCap":1640614867},{"date":"2024-10-11","current":-20.30237,"twenty":-43.311657,"median":-28.264591,"eighty":-20.195561,"marketCap":1686213351},{"date":"2024-10-18","current":-21.030656,"twenty":-43.248031,"median":-28.136018,"eighty":-20.195561,"marketCap":1746701137},{"date":"2024-10-25","current":-20.078282,"twenty":-43.248031,"median":-28.049113,"eighty":-20.145499,"marketCap":1667601725},{"date":"2024-10-31","current":-20.649706,"twenty":-43.248031,"median":-27.765641,"eighty":-20.132647,"marketCap":1715061372},{"date":"2024-11-08","current":-22.688907,"twenty":-43.252213,"median":-27.636067,"eighty":-20.132233,"marketCap":1884427173},{"date":"2024-11-15","current":-21.960621,"twenty":-43.252213,"median":-27.448241,"eighty":-20.132233,"marketCap":1823939387},{"date":"2024-11-22","current":-22.229527,"twenty":-43.231304,"median":-27.106738,"eighty":-20.132233,"marketCap":1846273338},{"date":"2024-11-29","current":-25.707412,"twenty":-43.145724,"median":-26.876224,"eighty":-20.132233,"marketCap":1914893729},{"date":"2024-12-06","current":-25.40483,"twenty":-43.145724,"median":-26.625426,"eighty":-20.132233,"marketCap":1892354961},{"date":"2024-12-13","current":-24.521289,"twenty":-43.145724,"median":-26.466422,"eighty":-20.132233,"marketCap":1826541758},{"date":"2024-12-20","current":-22.572657,"twenty":-43.145724,"median":-26.327469,"eighty":-20.132233,"marketCap":1681392092},{"date":"2024-12-27","current":-22.173248,"twenty":-43.145724,"median":-26.203648,"eighty":-20.132233,"marketCap":1651640919},{"date":"2025-01-03","current":-21.785943,"twenty":-43.145724,"median":-26.12294,"eighty":-20.132233,"marketCap":1622791296},{"date":"2025-01-10","current":-21.434947,"twenty":-43.151859,"median":-25.994723,"eighty":-20.130744,"marketCap":1596646325},{"date":"2025-01-17","current":-22.584761,"twenty":-43.151859,"median":-25.832017,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-24","current":-22.584761,"twenty":-43.151859,"median":-25.722549,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-31","current":-22.330591,"twenty":-43.151859,"median":-25.688138,"eighty":-20.130744,"marketCap":1663361078},{"date":"2025-02-07","current":-23.032583,"twenty":-43.151859,"median":-25.544418,"eighty":-20.130744,"marketCap":1715651020},{"date":"2025-02-14","current":-23.601438,"twenty":-43.151859,"median":-25.410136,"eighty":-20.130744,"marketCap":1758023904},{"date":"2025-02-21","current":-22.149042,"twenty":-43.151859,"median":-25.353801,"eighty":-20.130744,"marketCap":1649837817},{"date":"2025-02-28","current":-21.229191,"twenty":-43.151859,"median":-25.248903,"eighty":-20.130744,"marketCap":1581319962},{"date":"2025-03-07","current":-20.902402,"twenty":-43.157994,"median":-25.114351,"eighty":-20.129255,"marketCap":1556978093},{"date":"2025-03-14","current":-25.841364,"twenty":-43.157994,"median":-25.015259,"eighty":-20.118618,"marketCap":1407320673},{"date":"2025-03-21","current":-31.526661,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1716941957},{"date":"2025-03-28","current":-31.810986,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1732426315},{"date":"2025-04-04","current":-28.415807,"twenty":-43.157994,"median":-25.140052,"eighty":-20.118618,"marketCap":1547524873},{"date":"2025-04-11","current":-25.672904,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1398146368},{"date":"2025-04-17","current":-25.238054,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1374464410},{"date":"2025-04-25","current":-26.22483,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1428204238},{"date":"2025-05-02","current":-26.007405,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1416363259},{"date":"2025-05-09","current":-26.208105,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1427293394},{"date":"2025-05-16","current":-28.064582,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1528397138},{"date":"2025-05-23","current":-26.826931,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1460994642},{"date":"2025-05-30","current":-40.212905,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1483896395},{"date":"2025-06-06","current":-38.417271,"twenty":-42.89345,"median":-25.054079,"eighty":-20.118618,"marketCap":1417635735},{"date":"2025-06-13","current":-37.443101,"twenty":-42.85482,"median":-25.054079,"eighty":-20.118618,"marketCap":1381687885},{"date":"2025-06-20","current":-35.644634,"twenty":-42.692819,"median":-25.045717,"eighty":-20.116377,"marketCap":1315322623},{"date":"2025-06-27","current":-37.218293,"twenty":-42.4845,"median":-25.045717,"eighty":-20.116377,"marketCap":1373392227},{"date":"2025-07-03","current":-39.940973,"twenty":-42.385562,"median":-25.045717,"eighty":-20.116377,"marketCap":1473861860},{"date":"2025-07-11","current":-39.516335,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1458192284},{"date":"2025-07-18","current":-36.593825,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1350348733},{"date":"2025-07-25","current":-36.743697,"twenty":-42.001222,"median":-25.045717,"eighty":-20.116377,"marketCap":1355879172},{"date":"2025-08-01","current":-40.265697,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1485844477},{"date":"2025-08-08","current":-38.941825,"twenty":-41.552011,"median":-25.045717,"eighty":-20.116377,"marketCap":1436992270},{"date":"2025-08-15","current":-38.667059,"twenty":-41.27534,"median":-25.045717,"eighty":-20.116377,"marketCap":1426853133},{"date":"2025-08-22","current":-39.441399,"twenty":-41.020287,"median":-25.045717,"eighty":-20.116377,"marketCap":1455427065},{"date":"2025-08-29","current":-42.263994,"twenty":-40.940123,"median":-25.045717,"eighty":-20.116377,"marketCap":1559583657},{"date":"2025-09-05","current":-111.301894,"twenty":-40.946258,"median":-25.037354,"eighty":-20.114136,"marketCap":1545092897},{"date":"2025-09-12","current":-111.369065,"twenty":-41.159237,"median":-25.045717,"eighty":-20.116377,"marketCap":1546025361},{"date":"2025-09-19","current":-110.361504,"twenty":-41.502219,"median":-25.045717,"eighty":-20.116377,"marketCap":1532038401},{"date":"2025-09-26","current":-108.816577,"twenty":-41.627318,"median":-25.045717,"eighty":-20.116377,"marketCap":1510591728},{"date":"2025-10-03","current":-110.630187,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1535768257},{"date":"2025-10-10","current":-109.824138,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1524578689},{"date":"2025-10-17","current":-105.659553,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1466765919},{"date":"2025-10-24","current":-107.540334,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1492874912},{"date":"2025-10-31","current":-105.793895,"twenty":-41.746269,"median":-25.045717,"eighty":-20.116377,"marketCap":1468630847},{"date":"2025-11-07","current":-101.562139,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1409885613},{"date":"2025-11-14","current":-104.719163,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1453711422},{"date":"2025-11-21","current":-98.740968,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1370722124},{"date":"2025-11-28","current":6.997444,"twenty":-41.746269,"median":-24.978468,"eighty":-20.091839,"marketCap":1065227860},{"date":"2025-12-05","current":7.219871,"twenty":-41.569584,"median":-24.845699,"eighty":-20.051536,"marketCap":1099088196},{"date":"2025-12-12","current":7.833049,"twenty":-41.149298,"median":-24.524361,"eighty":-20.010479,"marketCap":1192432905},{"date":"2025-12-19","current":7.79698,"twenty":-40.783904,"median":-24.456235,"eighty":-19.933106,"marketCap":1186942040},{"date":"2025-12-26","current":7.839061,"twenty":-40.638471,"median":-24.290539,"eighty":-19.921421,"marketCap":1193348049},{"date":"2026-01-02","current":7.881142,"twenty":-40.445544,"median":-24.213538,"eighty":-19.883804,"marketCap":1199754059},{"date":"2026-01-09","current":7.616633,"twenty":-40.245714,"median":-24.133436,"eighty":-19.850083,"marketCap":1159487714},{"date":"2026-01-16","current":7.105652,"twenty":-40.140803,"median":-24.036721,"eighty":-19.806911,"marketCap":1081700456},{"date":"2026-01-23","current":6.738947,"twenty":-40.000922,"median":-23.900481,"eighty":-19.757821,"marketCap":1025876659},{"date":"2026-01-30","current":6.318139,"twenty":-39.844633,"median":-23.836174,"eighty":-19.718173,"marketCap":961816564},{"date":"2026-02-06","current":4.749124,"twenty":-39.429144,"median":-23.74822,"eighty":-19.674843,"marketCap":722963925},{"date":"2026-02-13","current":4.075831,"twenty":-39.135469,"median":-23.649661,"eighty":-19.608912,"marketCap":620467774},{"date":"2026-02-20","current":4.021727,"twenty":-38.923318,"median":-23.601935,"eighty":-19.561129,"marketCap":612231476},{"date":"2026-02-24","current":3.757219,"twenty":-38.764801,"median":-23.537754,"eighty":-19.535333,"marketCap":571965131}],"updateTime":1772058621877},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PD\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576068011","title":"NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576068011","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576068011?lang=en_us&edition=fundamental","pubTime":"2025-10-18 20:00","pubTimestamp":1760788800,"startTime":"0","endTime":"0","summary":"NUC-7738 Synergizes with PD-1 Inhibitors to Promote Cancer Cell Death Data Reinforces Mechanism of Action along with Efficacy and Safety Profile of NUC-7738 BERLIN, Oct.  18, 2025  (GLOBE NEWSWIRE) --","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/18/3168961/0/en/NuCana-Presents-Encouraging-Data-on-NUC-7738-in-Combination-with-PD-1-Inhibitors-using-Primary-Patient-Derived-Organoids-and-Autologous-Tumor-Infiltrating-Lymphocytes-at-the-ESMO-C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD"],"gpt_icon":0},{"id":"2576208059","title":"Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576208059","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576208059?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:00","pubTimestamp":1760702400,"startTime":"0","endTime":"0","summary":"6-month progression-free survival (PFS) of 50% in the higher 15 mg/kg dose cohort compares favorably to historical PD-(L)1 refractory settings –All clinical responses, including a complete response, o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/17/3168569/0/en/Sensei-Biotherapeutics-Reports-New-Clinical-Results-Highlighting-Durable-Progression-Free-Survival-Data-for-Solnerstotug-in-PD-L-1-Resistant-Tumors-at-the-ESMO-Congress-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4187","L","PFS","BK4139","IE00B7SZL793.SGD","IE0031619046.USD","BK4211","LU2487616109.SGD","IE00B19Z4B17.USD","BK4023","BK4006","PD","BK4213","BK4585","LU0053666078.USD","LU0963586101.USD","CRS","LU1169589451.USD","LU1169590202.USD","PR","LU2065731478.USD","LU0210528500.USD","BK4195","BK4588","IE00B66KJ199.SGD","BK4107","SNSE"],"gpt_icon":0},{"id":"2575754978","title":"Press Release: Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2575754978","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575754978?lang=en_us&edition=fundamental","pubTime":"2025-10-16 05:15","pubTimestamp":1760562900,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Oct. 15, 2025  -- Annovis Bio, Inc.  , a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease  and Parkinson's disease , today announced the closing of its previously announced registered direct offering for the purchase of an aggregate of 4,000,000 shares of its common stock  at a purchase price of $1.50 per share .H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.The aggregate gross proceeds to the Company from the offering were approximately $6 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering toward working capital and general corporate purposes.This press release contains forward-looking statements under the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","ANVS","LU1169590202.USD","BK4139","LU1169589451.USD","PD","AD","BK4132"],"gpt_icon":0},{"id":"2575905422","title":"NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2575905422","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575905422?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:00","pubTimestamp":1760443200,"startTime":"0","endTime":"0","summary":"NUC-3373 Plus Pembrolizumab Continues to Show Favorable Efficacy and Safety Profile in Heavily Pre-treated Patients Latest Data Cut-Off Shows Patient with Melanoma Remains Progression-Free at 23 Month","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/14/3166133/0/en/NuCana-Announces-Encouraging-Data-for-NUC-3373-in-Combination-with-Anti-PD-1-Therapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4139","NCNA","PD","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2575233403","title":"XPEL And 2 Stocks That Could Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2575233403","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575233403?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:08","pubTimestamp":1760353705,"startTime":"0","endTime":"0","summary":"As U.S.-China trade tensions flare up once more, major stock indexes have experienced notable declines, with the Nasdaq falling 3.6% and the S&P 500 down by 2.7% in a single session. In such volatile market conditions, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to navigate the current economic landscape effectively.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-pd/pagerduty/news/xpel-and-2-stocks-that-could-be-trading-below-estimated-valu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-pd/pagerduty/news/xpel-and-2-stocks-that-could-be-trading-below-estimated-valu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1169590202.USD","BK4124","LU1720051108.HKD","IE0009356076.USD","TEAM","PERF","BK4607","BK4548","BK4110","BK4613","LU1633808545.USD","BK4211","BK4532","BK4528","BK4116","LU1242518857.USD","LU1720051017.SGD","BK4023","LU1878469433.USD","BK4183","GKOS","ELF","LU0979878070.USD","BK4588","IE0009354923.USD","LU2065731478.USD","NPCE","LU1169589451.USD","AGNC","BK4227","BK4561","BLKB","LU0566484027.USD","LU1242518931.SGD","LU0053671581.USD","BK4082","CPAY","LU1559883803.SGD","LU2357305700.SGD","LU1548497426.USD","DCOM","BK4539","BK4585","PD","WIX","XPEL","LU0342679015.USD","TOWN","BK4566"],"gpt_icon":0},{"id":"1174643782","title":"Hong Kong Stock Alert | CSTONE PHARMA-B (02616) Rises Over 3% as Company to Present PD-1/VEGF/CTLA-4 Trispecific Antibody Phase I Dose Escalation Clinical Data at ESMO Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1174643782","media":"Stock News","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174643782?lang=en_us&edition=fundamental","pubTime":"2025-10-13 09:44","pubTimestamp":1760319860,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) surged over 3%, closing up 2.79% at HK$6.99 with a trading volume of HK$15.38 million as of press time. On the news front, CSTONE PHARMA-B announced that the 2025 European...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK4023","BK1574","LU1169589451.USD","YANG","07226","PD","HSCEI","BK4614","BK1161","LU1169590202.USD"],"gpt_icon":1},{"id":"1106947223","title":"CStone Pharma-B (02616) to Unveil Phase I Dose Escalation Clinical Data for PD-1/VEGF/CTLA-4 Triple Antibody and Latest Research Design for ROR1 ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=1106947223","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106947223?lang=en_us&edition=fundamental","pubTime":"2025-10-13 08:14","pubTimestamp":1760314460,"startTime":"0","endTime":"0","summary":"CStone Pharma-B (02616) announced that the 2025 European Society for Medical Oncology (ESMO) Annual Congress will be held from October 17-21, 2025, in Berlin, Germany. Abstracts for the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1161","BK4023","PD","ADC","BK4080","LU1169589451.USD","BK1574","LU1169590202.USD","BK4231"],"gpt_icon":0},{"id":"2574455350","title":"Strategic Advancements and Potential in Oncology: Kazia Therapeutics’ Buy Rating Driven by Novel PD-L1 Degrader and AI-Driven Paxalisib Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2574455350","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574455350?lang=en_us&edition=fundamental","pubTime":"2025-10-11 19:45","pubTimestamp":1760183114,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Naz Rahman from Maxim Group maintained...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strategic-advancements-and-potential-in-oncology-kazia-therapeutics-buy-rating-driven-by-novel-pd-l1-degrader-and-ai-driven-paxalisib-development-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strategic-advancements-and-potential-in-oncology-kazia-therapeutics-buy-rating-driven-by-novel-pd-l1-degrader-and-ai-driven-paxalisib-development-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PD","LENZ"],"gpt_icon":0},{"id":"2574317691","title":"Annovis Announces $6 Million Registered Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2574317691","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574317691?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:31","pubTimestamp":1760099460,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Oct.  10, 2025  (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neuro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/10/3164858/0/en/Annovis-Announces-6-Million-Registered-Direct-Offering-of-Common-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4132","AD","PD","ANVS","BK4023","LU1169590202.USD","LU1169589451.USD"],"gpt_icon":0},{"id":"2574118531","title":"How Investors May Respond To PagerDuty (PD) Unveiling Its End-to-End AI Agent Suite and Automation Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2574118531","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574118531?lang=en_us&edition=fundamental","pubTime":"2025-10-10 06:19","pubTimestamp":1760048376,"startTime":"0","endTime":"0","summary":"Earlier this week, PagerDuty announced the launch of the industry's first end-to-end AI agent suite, featuring more than 150 enhancements and deep integrations with tools such as Slack, Microsoft Teams, and Spotify Backstage.\nEarly adopters report incident resolution times improved by up to 50% and significant reductions in on-call fatigue, highlighting the operational impact of AI-driven automation.\nTo assess the potential impact on PagerDuty's investment narrative, we'll examine how this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-pd/pagerduty/news/how-investors-may-respond-to-pagerduty-pd-unveiling-its-end","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-pd/pagerduty/news/how-investors-may-respond-to-pagerduty-pd-unveiling-its-end","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","PD"],"gpt_icon":0},{"id":"1125496875","title":"Shanxi Securities Company Limited Initiates Coverage on 3SBIO (01530) with \"Buy-B\" Rating: PD-1/VEGF Bispecific Antibody Shows Promise as Potential Cornerstone Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1125496875","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125496875?lang=en_us&edition=fundamental","pubTime":"2025-10-09 15:21","pubTimestamp":1759994480,"startTime":"0","endTime":"0","summary":"Shanxi Securities Company Limited has issued a research report initiating coverage on 3SBIO (01530) with a \"Buy-B\" rating. The firm projects revenues of RMB 174.56/107.46/113.35 billion for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","PD","LU1169589451.USD","BK4023","BK1593","01530","002500","BK0028","BK0183","BK1583","BK1161","BK0276","LU1169590202.USD"],"gpt_icon":0},{"id":"1171698934","title":"Tianfeng Securities: Maintains \"Buy\" Rating on ABBISKO-B (02256) with Oral PD-L1 and Multi-Drug Combination Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1171698934","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171698934?lang=en_us&edition=fundamental","pubTime":"2025-10-09 14:15","pubTimestamp":1759990517,"startTime":"0","endTime":"0","summary":"Tianfeng Securities issued a research report maintaining a \"buy\" rating on ABBISKO-B (02256), projecting the company's operating revenue for 2025-2027 at RMB 630 million, RMB 685 million, and RMB 637...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","601162","BK1161","BK4023","BK0276","LU1169589451.USD","02256","LU1169590202.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2574183386","title":"A Fresh Look at PagerDuty (PD) Valuation Following Recent Share Pressure and Revenue Growth Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2574183386","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574183386?lang=en_us&edition=fundamental","pubTime":"2025-10-09 05:19","pubTimestamp":1759958350,"startTime":"0","endTime":"0","summary":"PagerDuty (PD) shares have been under pressure recently, slipping 2% after a week that saw further declines of 5%. With a year-to-date return of -13% and a muted revenue growth rate, investors are keeping a close watch on the company’s ability to regain momentum.\nSee our latest analysis for PagerDuty.\nPagerDuty’s share price has struggled to mount a comeback, with fading momentum reflected in its year-to-date decline of 13% and a one-year total shareholder return of -12.7%. After a stretch of...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-pd/pagerduty/news/a-fresh-look-at-pagerduty-pd-valuation-following-recent-shar","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-pd/pagerduty/news/a-fresh-look-at-pagerduty-pd-valuation-following-recent-shar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PD"],"gpt_icon":0},{"id":"2574791019","title":"Regeneron says FDA approves PD-1 inhibitor Libtayo","url":"https://stock-news.laohu8.com/highlight/detail?id=2574791019","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574791019?lang=en_us&edition=fundamental","pubTime":"2025-10-09 02:35","pubTimestamp":1759948521,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Pharmaceuticals announced that the U.S. Food and Drug Administration has approved the PD-1 inhibitor Libtayo as an adjuvant treatm...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-says-fda-approves-pd-1-inhibitor-libtayo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-says-fda-approves-pd-1-inhibitor-libtayo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","REGN","LU2023250504.SGD","LU1169589451.USD","LU0882574055.USD","LU0114720955.EUR","BK4139","LU1169590202.USD","LU0058720904.USD","LU0889565916.HKD","LU2468319806.SGD","LU2106854487.HKD","LU2362541513.USD","BK4588","LU2237438978.USD","LU0320765992.SGD","LU0053666078.USD","LU2362540622.SGD","LU1974910355.USD","LU2089984988.USD","LU0823434740.USD","BK4585","LU1917777945.USD","BK4023","LU0109394709.USD","LU0823434583.USD","PD","LU2362541273.HKD","LU0823416689.USD"],"gpt_icon":0},{"id":"2573927771","title":"PagerDuty (PD) Stock Is Up, What You Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2573927771","media":"stock_story_highlight","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573927771?lang=en_us&edition=fundamental","pubTime":"2025-10-08 23:36","pubTimestamp":1759937760,"startTime":"0","endTime":"0","summary":"Shares of digital operations platform PagerDuty (NYSE:PD) jumped 3.3% in the morning session after the company announced the launch of a suite of artificial intelligence (AI) agents designed to speed up incident response times.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_story_highlight","url":"https://stockstory.org/us/stocks/nyse/pd/news/why-up-down/pagerduty-pd-stock-is-up-what-you-need-to-know-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockstory.org/us/stocks/nyse/pd/news/why-up-down/pagerduty-pd-stock-is-up-what-you-need-to-know-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_story_highlight","symbols":["BK4023","PD","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2573595037","title":"Kazia Therapeutics signs collaboration and in-licensing agreement for PD-L1","url":"https://stock-news.laohu8.com/highlight/detail?id=2573595037","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573595037?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:35","pubTimestamp":1759840515,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics (KZIA) announced an exclusive collaboration and in-licensing agreement with QIMR Berghofer for a first-in-class PD-L1 degrader p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-signs-collaboration-and-in-licensing-agreement-for-pd-l1-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kazia-therapeutics-signs-collaboration-and-in-licensing-agreement-for-pd-l1-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","LU1169590202.USD","BK4007","BK4139","LU1169589451.USD","PD","KZIA","LENZ","BK4539"],"gpt_icon":0},{"id":"2572501753","title":"Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2572501753","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572501753?lang=en_us&edition=fundamental","pubTime":"2025-10-03 19:00","pubTimestamp":1759489200,"startTime":"0","endTime":"0","summary":"An expansive biomarker study confirmed OV329 delivered statistically significant inhibition of GABA-AT as measured across multiple metricsOV329 matched or exceeded inhibition demonstrated by therapeut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1d91b7ba967b27adf4977540771cf3d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/03/3160888/0/en/Ovid-announces-positive-topline-results-for-the-next-generation-GABA-aminotransferase-inhibitor-OV329-that-demonstrate-strong-inhibitory-activity-and-a-potential-best-in-category-s.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","PD","BK4211","BK4181","GABA","BK4218","LU1169590202.USD","LU1169589451.USD","BK4023"],"gpt_icon":0},{"id":"2571205366","title":"NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2571205366","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571205366?lang=en_us&edition=fundamental","pubTime":"2025-09-30 06:30","pubTimestamp":1759185000,"startTime":"0","endTime":"0","summary":"Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC nave or resistant to anti-PD-163% (26/41) disease control rate (“DCR”) and 37","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/29/3158214/0/en/NANOBIOTIX-Announces-Updated-Phase-1-Results-Continuing-to-Support-JNJ-1900-NBTXR3-Plus-Anti-PD-1-as-a-Potential-New-1L-or-2L-Option-in-Anti-PD-1-Na%C3%AFve-or-Resistant-R-M-HNSCC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNV92.GBP","LU2112291526.USD","LU2505996509.AUD","LU2129689431.USD","IE00B19Z3581.USD","IE00B2B36J28.USD","LU2129689605.HKD","LU2471134523.USD","LU2430703178.SGD","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU1261432733.SGD","IE00B19Z3B42.SGD","LU0098860793.USD","LU1718418525.SGD","LU0985320562.USD","BK4592","IE00BDGV0183.EUR","LU1267930813.SGD","BK4504","LU2468319806.SGD","LU2471134879.HKD","IE00BLSP4452.SGD","LU0432979614.USD","LU0640476718.USD","LU1074936037.SGD","LU1674673691.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","IE00BSNM7G36.USD","LU0795875169.SGD","IE00B42XCP33.USD","LU2347655156.SGD","LU0345769128.USD","LU1169589451.USD","LU0289739699.SGD","IE00B3T34201.USD","JNJ","LU1244550221.USD","LU1169590202.USD","LU2505996681.GBP","PD","BK4023","LU1506573853.SGD","NBTX","LU0114720955.EUR","LU2471134796.USD","IE0034235303.USD","BK4532"],"gpt_icon":0},{"id":"2571358366","title":"Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2571358366","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571358366?lang=en_us&edition=fundamental","pubTime":"2025-09-29 23:20","pubTimestamp":1759159200,"startTime":"0","endTime":"0","summary":"Larimar Therapeutics Inc. (NASDAQ: LRMR) is trading lower on Monday after the company released data from the ongoing long-term open-label (OL) study evaluating daily subcutaneous 25 mg and 50 mg injections of nomlabofusp self-administered or administered by a caregiver in participants with","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/29/Scientific-research.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/29/Scientific-research.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/09/47920098/larimar-therapeutics-stock-falls-after-patients-report-allergic-reaction-in-pivotal-study","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/09/47920098/larimar-therapeutics-stock-falls-after-patients-report-allergic-reaction-in-pivotal-study","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4130","LU1169589451.USD","FA","LRMR","BK4539","PD","BK4023","BK4535","BK4007","BK4139","BK4218","PK","LU1169590202.USD","LENZ","BK4181"],"gpt_icon":0},{"id":"2571438767","title":"Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2571438767","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571438767?lang=en_us&edition=fundamental","pubTime":"2025-09-29 19:00","pubTimestamp":1759143600,"startTime":"0","endTime":"0","summary":"In 4 completed studies and the ongoing OL study, 65 participants received at least 1 dose of nomlabofusp, including 39 in the OL study, with 14 on treatment for at least 6 months and 8 for over 1 year","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/29/3157570/0/en/Larimar-Therapeutics-Announces-Positive-Data-from-Ongoing-Long-term-Open-Label-Study-and-Updates-to-Nomlabofusp-Program-for-Friedreich-s-Ataxia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","BK4023","LU0971096721.USD","IE00B1BXHZ80.USD","LU2237443622.USD","LU2237443978.SGD","BK4006","BK4130","IE00BFXG1179.USD","LU2746668974.SGD","LENZ","PD","BK4539","LU0882574139.USD","BK4535","PK","BK4181","IE00BZ1G4Q59.USD","BK4007","LU0149725797.USD","LU1169589451.USD","LU2237443465.HKD","LU2237443549.SGD","LU1363072403.SGD","IE00BHPRN162.USD","LU0170899867.USD","FA","LU2237443895.HKD","BK4139","CMC","IE00BKVL7J92.USD","LU1169590202.USD","BK4218","LU2746668461.USD","LU0267386448.USD","FXN"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":199,"code":"91000000","status":"200"}]}}